SMT201600061B - Preparazione di cloroidrato di nalmefene a partire da naltrexone - Google Patents

Preparazione di cloroidrato di nalmefene a partire da naltrexone

Info

Publication number: SMT201600061B
Authority: SM; San Marino
Prior art keywords: chloroidrate; nalmefene; naltrexone; starting; preparation
Prior art date: 2009-05-25

Application number

SM201600061T

Other languages

English (en)

Inventor

Carla De Faveri

Mauro Casarin

Michele Brusegan

Original Assignee

Lundbeck & Co As H

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-05-25

Filing date

2016-02-26

Publication date

2016-07-01

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43222172&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SMT201600061(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2016-02-26 Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H

2016-07-01 Publication of SMT201600061B publication Critical patent/SMT201600061B/it

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
- C07D489/06—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
- C07D489/08—Oxygen atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Addiction (AREA)
Oil, Petroleum & Natural Gas (AREA)
Emergency Medicine (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Psychiatry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

SM201600061T 2009-05-25 2016-02-26 Preparazione di cloroidrato di nalmefene a partire da naltrexone SMT201600061B (it)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
DKPA200900650		2009-05-25
US18102209P	2009-05-26	2009-05-26
PCT/DK2010/050110 WO2010136039A1 (en)	2009-05-25	2010-05-21	Preparation of nalmefene hydrochloride from naltrexone

Publications (1)

Publication Number	Publication Date
SMT201600061B true SMT201600061B (it)	2016-07-01

Family

ID=43222172

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SM201600061T SMT201600061B (it)	2009-05-25	2016-02-26	Preparazione di cloroidrato di nalmefene a partire da naltrexone

Country Status (35)

Country	Link
US (1)	US8598352B2 (it)
EP (1)	EP2435439B8 (it)
JP (1)	JP5794980B2 (it)
KR (1)	KR101716522B1 (it)
CN (1)	CN102459276B (it)
AR (1)	AR076891A1 (it)
AU (1)	AU2010252392B2 (it)
BR (1)	BRPI1010975B1 (it)
CA (1)	CA2763093C (it)
CL (1)	CL2011002974A1 (it)
CO (1)	CO6470832A2 (it)
CR (1)	CR20110612A (it)
DK (1)	DK2435439T3 (it)
DO (1)	DOP2011000362A (it)
EA (1)	EA019331B1 (it)
ES (1)	ES2564006T3 (it)
GE (1)	GEP20146190B (it)
HR (1)	HRP20160110T1 (it)
HU (1)	HUE026892T2 (it)
IL (1)	IL216422A (it)
MA (1)	MA33368B1 (it)
ME (1)	ME02622B (it)
MX (1)	MX2011012502A (it)
MY (1)	MY158251A (it)
NZ (1)	NZ596988A (it)
PL (1)	PL2435439T3 (it)
RS (1)	RS54599B1 (it)
SG (1)	SG176205A1 (it)
SI (1)	SI2435439T1 (it)
SM (1)	SMT201600061B (it)
TN (1)	TN2011000590A1 (it)
TW (1)	TWI469985B (it)
UA (1)	UA106752C2 (it)
WO (1)	WO2010136039A1 (it)
ZA (1)	ZA201108659B (it)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2011154827A2 (en)	2010-06-11	2011-12-15	Rhodes Technologies	Transition metal-catalyzed processes for the preparation of n-allyl compounds and use thereof
JP6246589B2 (ja)	2010-11-05	2017-12-13	ハー・ルンドベック・アクチエゼルスカベット	ナルトレキソンの製造方法
CN103012416B (zh) *	2011-09-28	2015-07-01	辽宁海思科制药有限公司	一种盐酸纳美芬的制备方法
TWI560170B (en)	2011-12-06	2016-12-01	Lundbeck & Co As H	Process for recovery of nalmefene hydrochloride
CN102584840A (zh) *	2011-12-28	2012-07-18	南京优科生物医药有限公司	一种制备纳美芬化合物的方法
US20140155608A1 (en)	2012-05-03	2014-06-05	H. Lundbeck A/S	Method for the manufacturing of naltrexone
US20140005216A1 (en)	2012-06-27	2014-01-02	H. Lundbeck A/S	Nalmefene for reduction of alcohol consumption in specific target populations
CN103204859B (zh) *	2013-04-25	2015-12-02	四川海思科制药有限公司	一种盐酸纳美芬化合物及其制备方法
AR096851A1 (es)	2013-07-11	2016-02-03	H Lundbeck As	Sales que no forman hidratos ni solvatos de nalmefeno
CA2933733A1 (en)	2013-12-20	2015-06-25	Connie Sanchez Morillo	Use of an opioid receptor antagonist with kappa-activity and vortioxetine for treatment of depressive disorder with melancholic features
US20170042887A1 (en)	2014-04-22	2017-02-16	Otsuka Pharmaceutical. Co., Ltd.	Combination of Brexpiprazole and Nalmefene and Use Thereof for Treating Substance-Related Disorders
CN104513251A (zh) *	2014-11-28	2015-04-15	安徽悦康凯悦制药有限公司	一种盐酸纳美芬的制备方法
US9757372B2 (en) *	2015-03-25	2017-09-12	Taiwanj Pharmaceuticals Co., Ltd.	Toll-like receptor 4 antagonists and use in autoimmune liver diseases
RU2712232C1 (ru) *	2018-10-05	2020-01-27	Федеральное государственное унитарное предприятие "Научно-исследовательский институт гигиены, профпатологии и экологии человека" Федерального медико-биологического агентства	Улучшенный способ получения налмефена из налтрексона
US10927121B1 (en)	2019-12-20	2021-02-23	Southwest Research Institute	Technologies for removing residual solvent from nalmefene hydrochloride and producing crystalline nalmefene hydrochloride monohydrate, monosolvate, or crystalline nalmefene hydrochloride dihydrate
US20230399334A1 (en)	2020-11-02	2023-12-14	Rhodes Technologies	Process for purifying noroxymorphone
US20240109907A1 (en)	2021-01-28	2024-04-04	Rhodes Technologies	Process for crystallizing nalmefene hydrochloride
CN117843650A (zh) *	2023-12-27	2024-04-09	南京海纳医药科技股份有限公司	一种盐酸纳美芬的精制方法
CN117986261B (zh) *	2024-04-02	2024-06-18	成都瑞尔医药科技有限公司	一种盐酸纳美芬母液的回收套用方法
CN119080788A (zh) *	2024-08-19	2024-12-06	南京海鲸药业股份有限公司	一种盐酸纳美芬杂质的去除监控系统及去除方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4341764A (en)	1980-03-05	1982-07-27	Cutter Laboratories, Inc.	Method of preparing fibronectin and antihemophilic factor
US4322426A (en)	1980-04-28	1982-03-30	E. I. Du Pont De Nemours And Company	17-Substituted-6-desoxy-7,8-dihydro-6α-methylnoroxymorphone narcotic antagonists
US4535157A (en) *	1983-11-01	1985-08-13	Key Pharmaceuticals, Inc.	Process for making 6-desoxy-6-methylenenaloxone and 6-desoxy-6-methylenenaltrexone
US4751307A (en) *	1985-01-17	1988-06-14	Mallinckrodt, Inc.	Wittig-reaction processes
US4880813A (en) *	1988-07-22	1989-11-14	Baker Cummins Pharmaceuticals, Inc.	Method of treatment for allergic rhinitis
US7687646B2 (en)	2006-03-28	2010-03-30	Azad Pharmaceutical Ingredients, Ag	Polymorphic forms of olopatadine hydrochloride and methods for producing olopatadine and salts thereof
GB2447013A (en) *	2007-03-01	2008-09-03	Reckitt Benckiser Healthcare	Analgesic composition containing buprenorphone and nalmefene

2010
- 2010-05-21 WO PCT/DK2010/050110 patent/WO2010136039A1/en not_active Ceased
- 2010-05-21 JP JP2012512208A patent/JP5794980B2/ja active Active
- 2010-05-21 MY MYPI2011005679A patent/MY158251A/en unknown
- 2010-05-21 HR HRP20160110TT patent/HRP20160110T1/hr unknown
- 2010-05-21 EA EA201171461A patent/EA019331B1/ru not_active IP Right Cessation
- 2010-05-21 KR KR1020117028079A patent/KR101716522B1/ko not_active Expired - Fee Related
- 2010-05-21 ME MEP-2016-40A patent/ME02622B/me unknown
- 2010-05-21 PL PL10720257T patent/PL2435439T3/pl unknown
- 2010-05-21 EP EP10720257.4A patent/EP2435439B8/en active Active
- 2010-05-21 AU AU2010252392A patent/AU2010252392B2/en not_active Ceased
- 2010-05-21 US US13/321,597 patent/US8598352B2/en not_active Expired - Fee Related
- 2010-05-21 MX MX2011012502A patent/MX2011012502A/es active IP Right Grant
- 2010-05-21 SI SI201031133A patent/SI2435439T1/sl unknown
- 2010-05-21 BR BRPI1010975-7A patent/BRPI1010975B1/pt not_active IP Right Cessation
- 2010-05-21 HU HUE10720257A patent/HUE026892T2/en unknown
- 2010-05-21 NZ NZ596988A patent/NZ596988A/xx not_active IP Right Cessation
- 2010-05-21 MA MA34465A patent/MA33368B1/fr unknown
- 2010-05-21 SG SG2011086501A patent/SG176205A1/en unknown
- 2010-05-21 CA CA2763093A patent/CA2763093C/en active Active
- 2010-05-21 UA UAA201114599A patent/UA106752C2/uk unknown
- 2010-05-21 GE GEAP201012510A patent/GEP20146190B/en unknown
- 2010-05-21 DK DK10720257.4T patent/DK2435439T3/en active
- 2010-05-21 ES ES10720257.4T patent/ES2564006T3/es active Active
- 2010-05-21 CN CN201080033670.3A patent/CN102459276B/zh not_active Expired - Fee Related
- 2010-05-21 RS RS20160137A patent/RS54599B1/sr unknown
- 2010-05-24 TW TW99116496A patent/TWI469985B/zh not_active IP Right Cessation
- 2010-05-26 AR ARP100101818A patent/AR076891A1/es unknown
2011
- 2011-11-17 IL IL216422A patent/IL216422A/en not_active IP Right Cessation
- 2011-11-21 TN TNP2011000590A patent/TN2011000590A1/en unknown
- 2011-11-22 CR CR20110612A patent/CR20110612A/es unknown
- 2011-11-23 DO DO2011000362A patent/DOP2011000362A/es unknown
- 2011-11-24 CL CL2011002974A patent/CL2011002974A1/es unknown
- 2011-11-24 ZA ZA2011/08659A patent/ZA201108659B/en unknown
- 2011-11-25 CO CO11162008A patent/CO6470832A2/es active IP Right Grant
2016
- 2016-02-26 SM SM201600061T patent/SMT201600061B/it unknown

Also Published As

Publication number	Publication date
MX2011012502A (es)	2011-12-12
CO6470832A2 (es)	2012-06-29
MY158251A (en)	2016-09-30
CR20110612A (es)	2012-02-22
JP5794980B2 (ja)	2015-10-14
CL2011002974A1 (es)	2012-04-13
GEP20146190B (en)	2014-11-10
TN2011000590A1 (en)	2013-05-24
NZ596988A (en)	2013-03-28
HRP20160110T1 (hr)	2016-03-11
EP2435439B1 (en)	2016-01-06
PL2435439T3 (pl)	2016-05-31
EA201171461A1 (ru)	2012-05-30
HUE026892T2 (en)	2016-07-28
DK2435439T3 (en)	2016-02-29
KR20120023704A (ko)	2012-03-13
TWI469985B (zh)	2015-01-21
SG176205A1 (en)	2011-12-29
AR076891A1 (es)	2011-07-13
MA33368B1 (fr)	2012-06-01
EP2435439A1 (en)	2012-04-04
EA019331B1 (ru)	2014-02-28
BRPI1010975B1 (pt)	2021-08-24
TW201043634A (en)	2010-12-16
UA106752C2 (uk)	2014-10-10
BRPI1010975A2 (pt)	2015-10-20
CN102459276B (zh)	2016-09-21
IL216422A (en)	2015-06-30
IL216422A0 (en)	2012-02-29
CA2763093C (en)	2017-03-07
US20120123123A1 (en)	2012-05-17
JP2012527489A (ja)	2012-11-08
ES2564006T3 (es)	2016-03-17
KR101716522B1 (ko)	2017-03-14
WO2010136039A1 (en)	2010-12-02
US8598352B2 (en)	2013-12-03
RS54599B1 (sr)	2016-08-31
SI2435439T1 (sl)	2016-06-30
EP2435439B8 (en)	2016-05-18
CA2763093A1 (en)	2010-12-02
AU2010252392A1 (en)	2012-01-12
DOP2011000362A (es)	2012-07-15
ZA201108659B (en)	2013-02-27
AU2010252392B2 (en)	2014-10-23
CN102459276A (zh)	2012-05-16
ME02622B (me)	2017-06-20

Publication	Publication Date	Title
SMT201600061B (it)	2016-07-01	Preparazione di cloroidrato di nalmefene a partire da naltrexone
BRPI1009280A2 (pt)	2016-11-08	bracadeira de riser
SI2496562T1 (sl)	2014-06-30	Postopek priprave kalkobutrola
IL217197A (en)	2016-08-31	Quinoline derivative-containing pharmaceutical composition
ZA201005510B (en)	2012-01-25	Production of ethanol from methanol
DE112010002562T8 (de)	2012-11-22	Methanol-Synthese-Verfahren
EP2418213A4 (en)	2012-12-19	NEURO MEDIN-U DERIVATIVE
BRPI1011683A2 (pt)	2016-03-22	derivado isoquinolina substituída
PL2125824T3 (pl)	2014-05-30	Ulepszony sposób wytwarzania oksymorfonu z oripawiny
BR112012002807A2 (pt)	2015-10-13	derivados de 5-flúor-2-oxopirimidina-1(2h)-caboxilato
FI20095644A0 (fi)	2009-06-10	Ulokkeen muodostaminen
BRPI1007495A2 (pt)	2016-09-06	detonador
EP2484941A4 (en)	2015-03-25	Combined oil ring
SMT201500268B (it)	2016-01-08	Derivato di 5-idrossipirimidin-4-carbossammide
IT1396719B1 (it)	2012-12-14	Tazza da bagno pieghevole a mantice.
ZA201105099B (en)	2012-03-28	Novel forms of bendamustine free base
IL216062A0 (en)	2012-01-31	Novel isoquinoline derivatives
FR2946241B1 (fr)	2011-09-09	Zesteur a savon
IL219967A0 (en)	2012-07-31	Sustained-release formulation
PL2616810T3 (pl)	2014-12-31	Wytwarzanie elementu rozpoznawania molekularnego
IL210106A0 (en)	2011-02-28	Methods of synthesis of morphinans
IT1398700B1 (it)	2013-03-08	Apparecchio di illuminazione a tenuta stagna
FI20095440A0 (fi)	2009-04-22	Muodostusosa
UA19622S (uk)	2009-10-26	Прикраса настінна
HK1163514A (en)	2012-09-14	Novel forms of bendamustine free base